| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A mechanistic insight into the anti-metastatic role of the prostate specific antigen
|
Pellegrino, Francesco
|
|
|
14 |
11 |
p.
|
artikel
|
| 2 |
A preoperative model for predicting microvascular invasion and assisting in prognostic stratification in liver transplantation for HCC regarding empirical criteria
|
Zhang, Wenhui
|
|
|
14 |
11 |
p.
|
artikel
|
| 3 |
Bazedoxifene inhibits sustained STAT3 activation and increases survival in GBM
|
Wightman, Samantha M.
|
|
|
14 |
11 |
p.
|
artikel
|
| 4 |
Blocking GRP/GRP-R signaling decreases expression of androgen receptor splice variants and inhibits tumor growth in castration-resistant prostate cancer
|
Case, Thomas C.
|
|
|
14 |
11 |
p.
|
artikel
|
| 5 |
Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses
|
Tsakiridis, Evangelia E.
|
|
|
14 |
11 |
p.
|
artikel
|
| 6 |
Concerning FDA approval of trilaciclib (Cosela) in extensive-stage small-cell lung cancer
|
Powell, Kerrington
|
|
|
14 |
11 |
p.
|
artikel
|
| 7 |
Corrigendum to ‘Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model’ [Translational Oncology 13 (2020) 100754]
|
Agarwal, Sumit
|
|
|
14 |
11 |
p.
|
artikel
|
| 8 |
Cytotoxic capacity of a novel glycosylated antitumor ether lipid in chemotherapy-resistant high grade serous ovarian cancer in vitro and in vivo
|
Nachtigal, Mark W
|
|
|
14 |
11 |
p.
|
artikel
|
| 9 |
Delta-5-desaturase: A novel therapeutic target for cancer management
|
Pang, Lizhi
|
|
|
14 |
11 |
p.
|
artikel
|
| 10 |
Effect of aerobic exercise on acquired gefitinib resistance in lung adenocarcinoma
|
Yang, Hong
|
|
|
14 |
11 |
p.
|
artikel
|
| 11 |
Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study
|
Zeng, Fujuan
|
|
|
14 |
11 |
p.
|
artikel
|
| 12 |
Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments
|
Suzuki, Hiroyuki
|
|
|
14 |
11 |
p.
|
artikel
|
| 13 |
Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy
|
Baglo, Yan
|
|
|
14 |
11 |
p.
|
artikel
|
| 14 |
FGF9/FGFR1 promotes cell proliferation, epithelial-mesenchymal transition, M2 macrophage infiltration and liver metastasis of lung cancer
|
Chang, Ming-Min
|
|
|
14 |
11 |
p.
|
artikel
|
| 15 |
LAT1 inhibitor JPH203 sensitizes cancer cells to radiation by enhancing radiation-induced cellular senescence
|
Bo, Tomoki
|
|
|
14 |
11 |
p.
|
artikel
|
| 16 |
Loss of FAM60A attenuates cell proliferation in glioma via suppression of PI3K/Akt/mTOR signaling pathways
|
Liu, Xiaocen
|
|
|
14 |
11 |
p.
|
artikel
|
| 17 |
Macrophage polarization synergizes with oxaliplatin in lung cancer immunotherapy via enhanced tumor cell phagocytosis
|
Li, Fei
|
|
|
14 |
11 |
p.
|
artikel
|
| 18 |
Oncosuppressive role of MicroRNA-205–3p in gastric cancer through inhibition of proliferation and induction of senescence
|
Ma, Xiaoyu
|
|
|
14 |
11 |
p.
|
artikel
|
| 19 |
Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer
|
Bishnu, Aniketh
|
|
|
14 |
11 |
p.
|
artikel
|
| 20 |
Prognostic implications of ENE and LODDS in relation to lymph node-positive colorectal cancer location
|
Li, Tengfei
|
|
|
14 |
11 |
p.
|
artikel
|
| 21 |
Prolactin enhances T regulatory cell promotion of breast cancer through the long form prolactin receptor
|
Chen, Kuan-Hui Ethan
|
|
|
14 |
11 |
p.
|
artikel
|
| 22 |
Protein arginine methyltransferases and hepatocellular carcinoma: A review
|
Lei, Yu
|
|
|
14 |
11 |
p.
|
artikel
|
| 23 |
RNA editing signatures identify melanoma patients who respond to Pembrolizumab or Nivolumab treatment
|
Siddiqui, Jalal
|
|
|
14 |
11 |
p.
|
artikel
|
| 24 |
Vaccine-induced ErbB (EGFR/HER2)-specific immunity in spontaneous canine cancer
|
Doyle, Hester A.
|
|
|
14 |
11 |
p.
|
artikel
|
| 25 |
Will the clinical development of 4th-generation “double mutant active” ALK TKIs (TPX-0131 and NVL-655) change the future treatment paradigm of ALK+ NSCLC?
|
Ou, Sai-Hong Ignatius
|
|
|
14 |
11 |
p.
|
artikel
|
Tijdschrift beschrijving